Teza Capital Management »

Amicus Therapeutics shares owned by Teza Capital Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Teza Capital Management from 13F filings

Historical chart of Teza Capital Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Teza Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Teza Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $372k 40k 9.42
2024-09-30 $1.1M 108k 10.68

More positions owned by Teza Capital Management

Bank of America Corporation (BAC)
NVIDIA Corporation (NVDA)
Boston Scientific Corporation (BSX)
Schlumberger Com Stk (SLB)
Us Bancorp Del Com New (USB)
Ge Aerospace Com New (GE)
Truist Financial Corp equities (TFC)
Fifth Third Ban (FITB)
Morgan Stanley Com New (MS)
Chesapeake Energy Corp (EXE)
Micron Technology (MU)
Lam Research Corp Com New (LRCX)
AFLAC Incorporated (AFL)
Key (KEY)
Progressive Corporation (PGR)

View all positions for Teza Capital Management

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Pictet Asset Management Holding SA
Perceptive Advisors
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics